Sphera Funds Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Sphera Funds Management’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$1.33M	Sell
2022 Q4	$12.3M	Buy
2022 Q3	$12.3M	Buy
2022 Q2	$10.9M	Buy
2022 Q1	$11.5M	Buy
2021 Q4	$12M	Sell
2021 Q3	$11.5M	Sell
2021 Q2	$12M	Buy
2021 Q1	$4.34M	Buy